Zacks Research Has Positive Outlook of ESPR FY2027 Earnings
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Stock analysts at Zacks Research increased their FY2027 earnings estimates for shares of Esperion Therapeutics in a research note issued on Tuesday, May 27th. Zacks Research analyst K. Das now expects that the biopharmaceutical company will post earnings of $0.10 per share for the year, up from […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Stock analysts at Zacks Research increased their FY2027 earnings estimates for shares of Esperion Therapeutics in a research note issued on Tuesday, May 27th. Zacks Research analyst K. Das now expects that the biopharmaceutical company will post earnings of $0.10 per share for the year, up from […]
